Member Info for Chris0123

Pumpky - "cold sweats" it might be living in Norfolk as opposed to World Order. GLA

This particular idiom refers to a "future" event..one definition being "look out for what's coming". Usually has more positive connections in its association. Certainly think this is a positive whatever it refers to GLA

Not sure where you derived any sense of either of us being remotely nervous...however if that's the business you are in I am happy for you to provide a quotation ...and I can see you provide the hot air free. Thank you.

Or even .... the storm of some exiting times.. It's late!!!

Well put Brendy..we are in the lull before the storm of exciting some times. GLA

It's extremely encouraging that Hemogenyx have set up manufacturing capability..shows forward thinking. A slice of $37 billion will do most of us I am sure. GLA

I think ConsDoms & Bline have it about right. If you are patient and able to leave your money in, I think you/we are going to be okay. More reasons to add than sell in my view. GLA

Micky go to the Hemo website and register there. You will then be sent a zoom link to your email and then you access the meeting from there. GLA

Hi Folks,
This is not a scientific analysis but an observation of recent events. I myself would tend to presume that the situation with the IND application/ clinical trial being possibly Q1 2023 was likely known pre 30th May when the company financial controller acquired 1,284,889 shares (and who now holds 4 million) , took place in the knowledge of CAR T timescales. I think when looking at cash flow, which as an FC, he would or should be doing, he would have known about the timing of the clinical trials and it's associated financial requirements . Therefore, I think there is a high probability that other product news or deals is highly likely to be due in the intervening period. Some posters have eluded to this possibility. I am sure that if Andrew Wright thought there was very little likelihood of news on "anything" dropping over the next 9 months, his very increase in shareholding would probably have been delayed to take advantage of today's price. I take the view that if he's not worried, there's a little more reason for us not to worry. I also recall Mr India strongly advocating a Director purchase to instill confidence and there we had it on 30th May 2022.
I am not saying AW has insider information but it is reasonable to venture that his purchase reflects a positive environment in terms of what is happening within the business. Good luck everyone & as hard as it is, try not to get spooked.

Hi All
Thought this article was an interesting read about the biotech sector. Like many I have every confidence in this stock delivering on the science and the investment return. GLA

https://www.marketwatch.com/story/seven-reasons-the-beleaguered-biotech-sector-is-now-a-buy-11655475446

We were all there HT. It wasn't a party though it was business. At least, I did not recognize it as a party even though there was booze everywhere with vomiting and wine splattered walls and even a fight between a PI and a lab technician. Definitely business related though. Enough of that, let's get Car T done! GLA

Hi Hulver a well researched post and you are clearly and genuinely looking into Hemogenyx from different angles and that is a sensible and well-rounded approach. Among others you always give a great contribution.
If I can offer an alternative perception.
The Scientists you mention may simply have reached a point where raw research is done and clinical trials are not there primary aim in life.
The fact that they have been enticed away to other organisations is testimony to their capabilities.
Their career trajectory has changed now the Hemogenyx pipeline is where it is now.
The financial offer was too great.
VS is most probably difficult to work with.
VS is outsourcing the expertise of implementing the science now it is done.
I take your points but I don't think its too concerning and in biotechnology and pharma people job-hop a lot. Good luck to you and all.

Maybe it's a sign Cons ..another set of reasons to keep hold GLA

I urge everyone to read the link in my previous post. I read it twice and it resonates with Hemogenyx right now..the place we are at today. Advice to Hemo is concentrate on the science and we have heard this within many posts..particularly JHFH ....the money will follow. We are turning a corner everyone. IMO GLA

An industry overview for those interested GLA

https://www.geekwire.com/2022/biotech-stocks-are-getting-crushed-but-industry-insiders-say-theres-reason-for-optimism/

ACAR-T read. Good luck all

https://www.fiercebiotech.com/biotech/caribou-ready-uncork-chardonnay-thanks-first-human-car-t-results

Steady the ship everyone, no need to abandon it just yet. For comfort re-read the CBR update on 16/3/22 just 7 weeks ago. The science on this development and others is well-founded. The market will wake up to it eventually. GLA

Not easy counting that much cash 7 million and 1; 7 million and 2 (then suddenly!! an unwelcome interruption from a disgruntled shareholder, possibly Mr India and Mr Sandler loses count and has to restart) ....one; two; three...........!!! Who know?
GLA

Lighten up a bit HT. Please.

Agree about "adding value" I am sure most on here who bought even at its lowest have not waited this long for 3p. Let alone those who "need" significantly higher than that. GLA